1. No category

In Vivo Imaging
Systems Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016-2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
In vivo imaging system can be broken down into in vivo which means performed in living
organism and imaging systems which means visual representation system. In other words it
can be defined as the technique used for biological imaging in order to study the cellular
activity and the effects of drugs in various diseases. It can be subdivided into morphological
imaging systems and molecular imaging systems. High-frequency micro-ultrasound,
computed tomography (CT) scan and magnetic resonance imaging (MRI) constitute to
morphological imaging systems whereas fluorescence, bioluminescence, single photon
emission computed tomography (SPECT) and positron emission tomography (PET) constitute
to Molecular Imaging systems. In vivo Imaging systems can be used for both animals and
Humans depending upon the purpose of use. Usually in vivo imaging systems are used in
research laboratories to study the activity of a drug on the animals like albino mice albino
rats etc. These small animal imaging consist of full body scan and targeted scan. Full body
scan is popularly followed imaging method as it is economic and hence can be used for
commercialization and regular validation of new drugs. Small animal In vivo imaging includes
the measurement and classification of molecular level biological process that are used to
study the specific targeted drugs. Small animal In vivo imaging consist of micro MRI, micro CT,
micro PET, micro SPECT, digital angiography, x-ray imaging and magnetic particle imaging.
Human In vivo Imaging systems are used to study the deformity or the disorder caused to the
humans that may be disease induced, congenital or trauma induced. The imaging systems
used here are similar to that in animals like CT Scan, PET scan, SPECT scan, MRI scan etc.
In vivo Imaging Systems Market: Drivers and Restraints
Technological advancement of imaging systems, rise in the rate of adoption of multi-modality
Report
Description
Report Description
imaging systems in clinical and preclinical research studies, growth in the acceptance of
preclinical imaging for drug discovery and development process, growing awareness about
the benefits of early disease diagnosis are some of the crucial parameters driving the current
Imaging markets. A number of factors such as high implementation cost of sophisticated
clinical and preclinical imaging systems, High cost of maintenance, low life span of
accessories used are restricting the growth of the global imaging market
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/repgb-1742
In vivo Imaging Systems Market: Segmentation
Based on application, the In vivo Imaging Systems Market is segmented into the following:
•Monitoring Drug Treatment Response
•Bio Distribution Studies
•Cancer Cell Detection
•Biomarkers
•Longitudinal Studies
•Epigenetics
•Based on technology, In vivo Imaging Systems Market is segmented into the following:
Report
Description
Report Description
•Magnetic Resonance Imaging (MRI)
•Digital Angiography
•Ultrasound
•Nuclear Imaging
• Positron Emission Tomography (PET)
• Single Photon Emission Computerized Tomography (SPECT)
•Optical Imaging (OI)
•Bioluminescence Imaging
•Cerenkov Luminescence Imaging
•Others
• Ultrasound Imaging
• Computerized Tomography (CT)
Based on end user, the in vivo imaging systems market can be segmented into following:
• Hospitals
• Clinics
• Pharmaceutical Research Institutes
• Diagnostic Laboratories
Report
Description
Report Description
• Forensic Laboratories
• Educational research institutes
Based on geography, the in vivo Imaging Systems market is segmented into following:
• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
• Eastern Europe (Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa)
In vivo Imaging Systems Market: Overview
The in vivo market has some well establish technology, but on and off there are some of the
technological advancement taking place in the market. In case of MRI the currently used
technology for diagnostic purpose ranges from 1.5 T to 3 T, for human clinical studies 9.4 T
and animal clinical studies 21. T.
The combination of PET-MRI at 9.4 T is operational since 2009, but presently only brain can
be imaged such high magnetic field strengths.
Report
Description
Report Description
In vivo Imaging Systems Market: Region-wise Outlook
North America market is a leader for In vivo imaging systems followed by the European
market. Research Institutes and Pharmaceutical companies, growing usage for in vivo
imaging system and technological advancements, rising awareness and applications of
functional imaging that are factors driving market growth. Asia-Pacific market is also growing
at fastest pace due to growing number of research institutes, increasing number of funds
given by government for research and rising industry-academia partnerships for small animal
research and increasing medical tourism.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1742
In vivo Imaging Systems Market: Key Players
The research report presents a comprehensive assessment of the market and contains
thoughtful insights, facts, historical data, and statistically supported and industry-validated
market data. It also contains projections using a suitable set of assumptions and
methodologies. The research report provides analysis and information according to
categories such as market segments, geographies, types, technology and applications. The
key players in the in vivo imaging system market include Bruker Corporation, Life
Technologies Corporation, Miltenyi Viotech GmbH, Biosacan, Inc., Gamma Meddica,
Targeson, Inc., Sanco Medical, Aspect Imaging, Mediso Medical Imaging Systems, Perkin
Elmer, Inc., FUJIFILM Holdings Corporation and Siemens AG.
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705